{"id":14297,"date":"2011-11-23T09:30:00","date_gmt":"2011-11-23T08:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/merck-paghera-950-milioni-per-chiudere-cause-su-vioxx\/"},"modified":"2011-11-23T09:30:00","modified_gmt":"2011-11-23T08:30:00","slug":"merck-paghera-950-milioni-per-chiudere-cause-su-vioxx","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/merck-paghera-950-milioni-per-chiudere-cause-su-vioxx\/","title":{"rendered":"Merck to pay $950 million to settle Vioxx lawsuits"},"content":{"rendered":"<p style=\"margin: 0cm 0cm 3pt; background: white\" class=\"autore\"><span style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;\"><font size=\"4\">Merck (US5893311077) has announced that it will pay $950 million to settle the lawsuits brought against it for having sold the anti-arthritis drug Vioxx without having the necessary authorization. The US group had had to withdraw the product from the market in September 2004 because studies had indicated serious collateral risks for the cardiovascular system. The story caused a scandal because Merck had already known much earlier about the risks of Vioxx. In 2007, the pharmaceutical industry giant had already agreed to pay $4.85 billion for the resolution of most of the lawsuits related to Vioxx<\/p>\n<p><\/font><\/span><\/p>\n<p style=\"margin: 0cm 0cm 3pt; background: white\" class=\"autore\"><em style=\"mso-bidi-font-style: normal\"><span style=\"font-family: &quot;Verdana&quot;,&quot;sans-serif&quot;; color: #006199; font-size: 9pt; mso-bidi-font-weight: bold\">Wednesday, November 23, 2011 <img","protected":false},"excerpt":{"rendered":"<p>Merck (US5893311077) ha annunciato che pagher&agrave; $950 milioni per chiudere le cause legali avviate nei suoi confronti per aver venduto il farmaco antiartrite Vioxx senza avere la necessaria autorizzazione. Il gruppo statunitense aveva dovuto ritirare il prodotto dal mercato nel settembre 2004 perch&eacute; degli studi avevano indicato dei seri rischi collaterali per l&#8217;apparato cardiovascolare. La &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-14297","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/14297","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=14297"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/14297\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=14297"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=14297"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=14297"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}